Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

28 August 2017 (11:28 - 11:33)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Clinical Trials 2 Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

ESC 365 is supported by

ESC 365 is supported by